Anti-htrA1 antibody [EPR23240-64]
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Knockout Tested Rabbit Recombinant Monoclonal HTRA1 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
HTRA, PRSS11, HTRA1, Serine protease HTRA1, High-temperature requirement A serine peptidase 1, L56, Serine protease 11
- WB
Lab
Western blot - Anti-htrA1 antibody [EPR23240-64] (AB274322)
ab274322 was shown to react with HTRA1 in wild-type HAP1 cells in Western blot with loss of signal observed in a HTRA1 knockout cell line. Wild-type HAP1 and HTRA1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab274322 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2ug/mL before imaging.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-htrA1 antibody [EPR23240-64] (ab274322) at 1/1000 dilution
Lane 1:
Wild-type HAP1 lysate at 20 µg
Lane 2:
HTRA1 Knockout HAP1 lysate at 20 µg
Observed band size: 51 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-htrA1 antibody [EPR23240-64] (AB274322)
htrA1 was immunoprecipitated from 0.35 mg Human placenta lysate with ab274322 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab274322 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Human placenta lysate 10 ug
Lane 2 : ab274322 IP in Human placenta lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab274322 in Human placenta lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 7.75 seconds.
All lanes:
Immunoprecipitation - Anti-htrA1 antibody [EPR23240-64] (ab274322)
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
- WB
Lab
Western blot - Anti-htrA1 antibody [EPR23240-64] (AB274322)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 16767218, 19103920).
Exposure time : 48 seconds.
All lanes:
Western blot - Anti-htrA1 antibody [EPR23240-64] (ab274322) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 20 µg
Lane 2:
Human placenta tissue lysate at 20 µg
Lane 3:
Human ovary tissue lysate at 20 µg
Lane 4:
Human ovary cancer tissue lysate at 20 µg
Secondary
All lanes:
VeriBlot for IP secondary antibody(HRP)(<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
- WB
Lab
Western blot - Anti-htrA1 antibody [EPR23240-64] (AB274322)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : HepG2, MCF7 (PMID : 14716297, 22761798).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-htrA1 antibody [EPR23240-64] (ab274322) at 1/1000 dilution
Lane 1:
SK-OV-3 (human ovarian cancer epithelial cell), whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
Related conjugates and formulations (1)
-
Anti-htrA1 antibody [EPR23240-64] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HtrA1 participates in cellular processes including protein degradation and modulation of signaling pathways. It does not have a known direct association with protein complexes but its protease activity affects extracellular matrix components and influences cellular homeostasis. HtrA1's regulatory function can affect cell growth and differentiation impacting tissue development and repair mechanisms.
Pathways
HtrA1 interacts significantly with the TGF-beta signaling pathway where its protease activity modulates the availability and activity of TGF-beta ligands and receptors. It also plays a role in the Wnt signaling pathway by influencing the stability of pathway-related proteins. HtrA1 interacts with proteins such as TGF-beta contributing to the regulation of extracellular matrix and cellular responses to external signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Proceedings of the National Academy of Sciences of the United States of America 120:e2215005120 PubMed37126685
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of reproductive immunology (New York, N.Y. : 1989) 87:e13523 PubMed35137483
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of reproductive immunology (New York, N.Y. : 1989) 86:e13485 PubMed34270834
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com